Ltr Pharma Limited has released a press release.
FY26 Results Announcement
Earlier from Ltr Pharma
- SPONTAN Real-World Study Reports 93% Response
- LTR Executes U.S. Commercial Agreement with Strive
- LTR Executes Definitive U.S. Commercial Agreement with Shed
- Response to ASX Aware Letter